Title: SR 16 Text
Official Title: 
Number of Sections: 1
Source: versions - Introduced Version
Media Type: text/html

================================================================================

Section 1:
SR 16 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version Senate Resolution 16 History |  Email Key: Green = existing Code. Red = new code to be enacted SENATE RESOLUTION 16(By Senator Rucker)[Introduced February 27, 2025] Designating the first full week in May as Tardive Dyskinesia Awareness Week.Whereas, Serious mental illnesses like bipolar disorder, major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise; andWhereas, While prolonged antipsychotic use may be essential for the treatment of certain conditions, it is associated with tardive dyskinesia (TD), a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities; andWhereas, People at higher risk of TD include those older than 55 years, Black individuals, women, individuals with mood or substance use disorders, intellectual disabilities, or central nervous system injuries, and those with high cumulative antipsychotic exposure; andWhereas, Approximately 60 percent of the estimated 800,000 U.S. adults living with TD remain undiagnosed and even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention; andWhereas, The American Psychiatric Association recommends routine TD screening in its clinical guidelines for antipsychotic treatment and individuals treated with antipsychotics or experiencing abnormal movements should consult their health care providers to assess TD risk, receive TD screenings, and determine appropriate treatment together; andWhereas, FDA-approved treatments for TD can provide options for symptom management and improved quality of life for many individuals living with TD; andWhereas, The West Virginia Senate can encourage TD screening education and awareness for health care providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinical best practice, including regular TD screenings; therefore, be it Resolved by the Senate:That the Senate hereby designates the first full week in May as Tardive Dyskinesia Awareness Week; and, be itFurther Resolved, That in recognition and support of Tardive Dyskinesia Awareness Week, the Senate underscores the importance of early detection and intervention to improve outcomes for people living with mental health conditions and prescribed antipsychotics, and supports efforts to raise awareness about the causes and symptoms of TD and the importance of routine TD screening; and, be itFurther Resolved, That the Clerk of the Senate is hereby directed to forward a copy of this resolution to Neurocrine Biosciences, c/o Karla Kiriako, 905 Juniper Street, NE, Unit 816, Atlanta, GA 30309. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone:


================================================================================

Raw Text:
SR 16 Text skip navigation SENATE PRESIDENT SENATORS COMMITTEES VIDEO/AUDIO DISTRICT MAPS SENATE CLERK SENATE RULES HOUSE SPEAKER DELEGATES COMMITTEES VIDEO/AUDIO DISTRICT MAPS HOUSE CLERK HOUSE RULES HOUSE STAFF JOINT INTERIM COMMITTEES LEGISLATIVE ADMINISTRATOR LEGISLATIVE SERVICES DIVISION PUBLIC INFORMATION LEGISLATIVE AUTOMATED SYSTEMS DIVISION LEGISLATIVE AUDITOR'S OFFICE PERFORMANCE EVALUATION & RESEARCH DIVISION POST AUDIT DIVISION BUDGET DIVISION REGULATORY AND FISCAL AFFAIRS DIVISION CLAIMS COMMISSION CRIME VICTIMS RULE-MAKING REVIEW SPECIAL INVESTIGATIONS JUDICIAL COMP. COMMISSION JOINT RULES STAFF INFO BILL STATUS BILL STATUS BILL TRACKING STATE LAW WEST VIRGINIA CODE ACTS OF THE LEGISLATURE CODE OF 1931 WV CONSTITUTION US CONSTITUTION REPORTS AGENCY REPORTS AGENCY GRANT AWARDS PERFORMANCE EVALUATIONS POST AUDITS EDUCATIONAL CITIZEN’S GUIDE INTERNSHIP PROGRAM PAGE PROGRAM PUBLICATIONS PHOTO GALLERY CAPITOL HISTORY HOW A BILL BECOMES LAW CONTACT SENATE ROSTER HOUSE ROSTER PUBLIC INFO. NEWS RELEASES HELPFUL LINKS Introduced Version Senate Resolution 16 History |  Email Key: Green = existing Code. Red = new code to be enacted SENATE RESOLUTION 16(By Senator Rucker)[Introduced February 27, 2025] Designating the first full week in May as Tardive Dyskinesia Awareness Week.Whereas, Serious mental illnesses like bipolar disorder, major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise; andWhereas, While prolonged antipsychotic use may be essential for the treatment of certain conditions, it is associated with tardive dyskinesia (TD), a condition marked by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, or extremities; andWhereas, People at higher risk of TD include those older than 55 years, Black individuals, women, individuals with mood or substance use disorders, intellectual disabilities, or central nervous system injuries, and those with high cumulative antipsychotic exposure; andWhereas, Approximately 60 percent of the estimated 800,000 U.S. adults living with TD remain undiagnosed and even mild TD symptoms can be stigmatizing and impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention; andWhereas, The American Psychiatric Association recommends routine TD screening in its clinical guidelines for antipsychotic treatment and individuals treated with antipsychotics or experiencing abnormal movements should consult their health care providers to assess TD risk, receive TD screenings, and determine appropriate treatment together; andWhereas, FDA-approved treatments for TD can provide options for symptom management and improved quality of life for many individuals living with TD; andWhereas, The West Virginia Senate can encourage TD screening education and awareness for health care providers, patients, and care partners to help ensure patients prescribed antipsychotics receive care and support that aligns with clinical best practice, including regular TD screenings; therefore, be it Resolved by the Senate:That the Senate hereby designates the first full week in May as Tardive Dyskinesia Awareness Week; and, be itFurther Resolved, That in recognition and support of Tardive Dyskinesia Awareness Week, the Senate underscores the importance of early detection and intervention to improve outcomes for people living with mental health conditions and prescribed antipsychotics, and supports efforts to raise awareness about the causes and symptoms of TD and the importance of routine TD screening; and, be itFurther Resolved, That the Clerk of the Senate is hereby directed to forward a copy of this resolution to Neurocrine Biosciences, c/o Karla Kiriako, 905 Juniper Street, NE, Unit 816, Atlanta, GA 30309. Bill Status  | Bill Tracking  | Legacy WV Code  | Bulletin Board  | District Maps  | Senate Roster  | House Roster  | Live  | Blog  | Jobs  | Links  | Home This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  | Terms of Use | Webmaster | © 2025 West Virginia Legislature ** Print On Demand Name: Email: Phone: